Time Course of Dopamine-D2and Serotonin-5-HT2Receptor Occupancy Rates by Haloperidol and Clozapine In Vivo
- 1 March 1993
- journal article
- research article
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 47 (1) , 131-137
- https://doi.org/10.1111/j.1440-1819.1993.tb02041.x
Abstract
In vivo occupancy of dopamine-D1, D2 and serotonin-5-HT2 receptors by haloperidol 10 mg/kg and clozapine 20 mg/kg were studied. Rats were injected intravenously with [3H]-YM-09151-2, [3H]-SCH23390, or [3H]-ketanserin 10 min after the administration of the tested drugs. Fifteen to 240 min after the ligand injection, the receptor occupancy rates of the drugs in the striatum and frontal cortex were calculated. Clozapine demonstrated the higher 5-HT2 and lower D2 occupancies in the respective regions. A dose-response analysis of D2 and 5-HT2 receptor occupancy by the drugs consolidated the higher 5-HT2 binding affinity of clozapine in comparison with haloperidol. The present methodology may serve as an accurate tool to evaluate the peculiarity of various antipsychotics.Keywords
This publication has 14 references indexed in Scilit:
- Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysisJournal of Neuroscience, 1989
- Dopamine receptor occupancy in vivo: Measurement using N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ)Life Sciences, 1989
- Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortexLife Sciences, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptorsEuropean Journal of Pharmacology, 1988
- In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptorsLife Sciences, 1987
- Dopamine denervation does not alter in vivo 3H‐spiperone binding in rat striatum: Implications for external imaging of dopamine receptors in Parkinson's diseaseAnnals of Neurology, 1986
- Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivoEuropean Journal of Pharmacology, 1986
- Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976